Stephen Lakner, MD
Obstetrics & Gynecology · Rockville, MDNPI 1043295389
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 26.1% of the total. Reporting peaked in 2019 at $600 and has fallen 56.9% since, to $258 in 2025.
Across 73 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$461
- Astellas Pharma US Inc$194
- Aspira Women's Health Inc$161
- Bayer$105
- Myovant Sciences Inc.$84
- Therapeuticsmd, Inc.$82
- plus $678 from 19 others
What the payments were for
- Food & beverage$1,74399%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $461 |
| Astellas Pharma US Inc | 8 | $194 |
| Aspira Women's Health Inc | 2 | $161 |
| Bayer | 5 | $105 |
| Myovant Sciences Inc. | 5 | $84 |
| Therapeuticsmd, Inc. | 4 | $82 |
| Smith+Nephew | 1 | $78 |
| Coopersurgical, Inc. | 3 | $76 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Exact Sciences | 3 | $62 |
| Sage Therapeutics, LLC | 3 | $51 |
| Mayne Pharma Commercial LLC | 3 | $39 |
| Gilead | 1 | $34 |
| Organon | 1 | $34 |
| Pfizer | 2 | $30 |
| Merck | 1 | $26 |
| Shield Therapeutics Inc | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $23 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| Distalmotion US | 1 | $20 |
| Exeltis, USA Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$115
How this compares
$1,763 in reported general payments places this provider in the 70th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Rockville
- Steven BehramRockville$18K
- Carolynn YoungRockville$11K
- James RobinsonRockville$7K
- Genesis Millan-SerranoRockville$6K
- Albert SterenRockville$6K
- Otis StittSilver Spring$641K
- Danielle ShillerBaltimore$221K
- Matthew ReevesChevy Chase$149K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.